Literature DB >> 21071283

Skin vascular resistance in the standing position increases significantly after 7 days of dry immersion.

Nastassia M Navasiolava1, Victor de Germain, Thibaud Levrard, Irina M Larina, Inesa B Kozlovskaya, Bertrand Diquet, Anne Le Bouil, Marc-Antoine Custaud, Jacques-Olivier Fortrat.   

Abstract

Actual and simulated microgravity induces hypovolemia and cardiovascular deconditioning, associated with vascular dysfunction. We hypothesized that vasoconstriction of skin microcirculatory bed should be altered following 7 days of simulated microgravity in order to maintain cardiovascular homeostasis during active standing. Eight healthy men were studied before and after 7 days of simulated microgravity modeled by dry immersion (DI). Changes of plasma volume and orthostatic tolerance were evaluated. Calf skin blood flow (laser-Doppler flowmetry), ECG and blood pressure signal during a 10-min stand test were recorded, and skin vascular resistance, central hemodynamics, baroreflex sensitivity and heart rate variability were estimated. After DI we observed increased calf skin vascular resistance in the standing position (12.0 ± 1.0 AU-after- vs. 6.8 ± 1.4 AU-before), while supine it was unchanged. Cardiovascular deconditioning was confirmed by greater tachycardia on standing and by hypovolemia (-16 ± 3% at day 7 of DI). Total peripheral resistance and indices of cardiovascular autonomic control were not modified. In conclusion, unchanged autonomic control and total peripheral resistance suggest that increased skin vasoconstriction to standing involves rather local mechanisms-as venoarteriolar reflex-and might compensate insufficient vasoconstriction of other vascular beds.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21071283     DOI: 10.1016/j.autneu.2010.10.003

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  6 in total

Review 1.  Long-term dry immersion: review and prospects.

Authors:  Nastassia M Navasiolava; Marc-Antoine Custaud; Elena S Tomilovskaya; Irina M Larina; Tadaaki Mano; Guillemette Gauquelin-Koch; Claude Gharib; Inesa B Kozlovskaya
Journal:  Eur J Appl Physiol       Date:  2010-12-14       Impact factor: 3.078

2.  Effects of plantar stimulation on cardiovascular response to orthostatism.

Authors:  Liubov E Amirova; Nastassia M Navasiolava; Marie-Pierre Bareille; Arnaud Beck; Elena S Tomilovskaya; Inessa B Kozlovzkaya; Guillemette Gauquelin-Koch; Claude Gharib; Marc-Antoine Custaud
Journal:  Eur J Appl Physiol       Date:  2016-09-29       Impact factor: 3.078

3.  Craniomandibular System and Postural Balance after 3-Day Dry Immersion.

Authors:  Loïc Treffel; Liubov Dmitrieva; Guillemette Gauquelin-Koch; Marc-Antoine Custaud; Stéphane Blanc; Claude Gharib; Catherine Millet
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

4.  Multi-System Deconditioning in 3-Day Dry Immersion without Daily Raise.

Authors:  Steven De Abreu; Liubov Amirova; Ronan Murphy; Robert Wallace; Laura Twomey; Guillemette Gauquelin-Koch; Veronique Raverot; Françoise Larcher; Marc-Antoine Custaud; Nastassia Navasiolava
Journal:  Front Physiol       Date:  2017-10-13       Impact factor: 4.566

5.  Cardiovascular System Under Simulated Weightlessness: Head-Down Bed Rest vs. Dry Immersion.

Authors:  Liubov Amirova; Nastassia Navasiolava; Ilya Rukavishvikov; Guillemette Gauquelin-Koch; Claude Gharib; Inessa Kozlovskaya; Marc-Antoine Custaud; Elena Tomilovskaya
Journal:  Front Physiol       Date:  2020-05-19       Impact factor: 4.566

6.  A dry immersion model of microgravity modulates platelet phenotype, miRNA signature, and circulating plasma protein biomarker profile.

Authors:  Laura Twomey; Nastassia Navasiolava; Adrien Robin; Marie-Pierre Bareille; Guillemette Gauquelin-Koch; Arnaud Beck; Françoise Larcher; Gerardene Meade-Murphy; Sinead Sheridan; Patricia B Maguire; Michael Harrison; Bernard Degryse; Niall M Moyna; Claude Gharib; Marc-Antoine Custaud; Ronan P Murphy
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.